<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">On April 15 (As of this date, 76,389 patients with COVID- 19 have been identified in Iran, of which 4777 deaths have been occurred by the virus, and according to statistics, Iran ranks sixth in the number of deaths due to COVID- 19) a 41-year-old male was referred to emergency department for acute onset of cough, dyspnea, and fever. Regarding symptom profile and chest CT scan findings (obtained same day) of multiple ground glass opacities and consolidations, typical of COVID-19 pneumonia (
 <xref rid="f0005" ref-type="fig">Fig. 1</xref> ) the patient diagnosed as COVID-19 and was admitted to hospital. At the time of admission, the patient was febrile with an oral temperature of 39 °C, the blood pressure was 110/70 mmHg, the pulse was 110 beats per minute and the respiratory rate was 22 breaths per minute. O
 <sub>2</sub> saturation was 88% on room air. His medical history included type 2 diabetes mellitus under treatment with metformin and gliclazide. Laboratory data revealed lymphopenia (WBC:5.9 × 10
 <sup>9</sup>/L, PMN:85%, Lymphocyte:15%), elevated levels of C-reactive protein (CRP: ++) and erythrocyte sedimentation rate (ESR:69 mm/h), glucose (280 mg/dL) and HbA1c (8.7%).
</p>
